Logo

CCLD

CareCloud, Inc.

CCLD

CareCloud, Inc. NASDAQ
$3.10 -0.32% (-0.01)

Market Cap $131.43 M
52w High $4.84
52w Low $1.14
Dividend Yield 0%
P/E 44.29
Volume 126.83K
Outstanding Shares 42.40M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $31.067M $11.633M $3.06M 9.85% $0.04 $7.331M
Q2-2025 $27.377M $9.901M $2.902M 10.6% $0.04 $6.46M
Q1-2025 $27.632M $10.149M $1.948M 7.05% $-0.04 $5.454M
Q4-2024 $28.239M $9.78M $3.296M 11.672% $0.001 $6.662M
Q3-2024 $28.546M $9.861M $3.122M 10.937% $-0.041 $6.225M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $5.073M $90.576M $32.772M $57.804M
Q2-2025 $10.44M $75.244M $19.168M $56.076M
Q1-2025 $6.805M $73.556M $19.379M $54.177M
Q4-2024 $5.145M $71.614M $21.84M $49.774M
Q3-2024 $2.782M $70.694M $24.186M $46.508M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $3.06M $7.365M $-17.697M $4.92M $-5.367M $6.496M
Q2-2025 $2.902M $7.408M $-1.993M $-1.762M $3.635M $6.246M
Q1-2025 $1.948M $5.113M $-1.51M $-1.932M $1.66M $4.489M
Q4-2024 $3.296M $5.229M $-2.262M $-578K $2.363M $4.291M
Q3-2024 $3.122M $7.068M $-1.673M $-5.166M $165K $6.734M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Remote Patient Monitoring
Remote Patient Monitoring
$0 $0 $0 $0
Revenue Cycle Management
Revenue Cycle Management
$0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Revenue has been broadly flat over the last few years, with a small step down from its earlier peak, suggesting the business is stabilizing rather than in strong growth mode. Profitability has been choppy: the company moved from modest profit to a meaningful loss and then back to a small profit at the operating and net income level in the most recent year. This points to active cost control and efficiency efforts, but also highlights that margins are thin and vulnerable to any slowdown in sales or rise in expenses. Reported earnings per share look highly volatile and more negative than headline profit would suggest, likely reflecting share-count or one-off accounting effects, so the underlying trend should be read with caution.


Balance Sheet

Balance Sheet The balance sheet shows a relatively small asset base that has shrunk from prior years, which limits financial flexibility but also suggests some past streamlining. Cash is on the lighter side, though still present, while debt levels appear modest, meaning leverage risk is not extreme. Equity remains positive but lower than a few years ago, indicating that past losses and write-downs have eaten into the cushion while still leaving some buffer for the business to operate. Overall, the balance sheet looks serviceable but not especially strong, making consistent profitability and cash generation important.


Cash Flow

Cash Flow Operating cash flow has been steadily positive for several years, a notable strength that suggests the core business model does convert revenue into cash. Free cash flow has generally hovered around breakeven to modestly positive, helped by relatively low capital spending needs for a software- and services-based company. This pattern implies the company can mostly fund its operations and small investments internally, though it does not yet generate the kind of surplus cash that would easily support large acquisitions or major new initiatives without external funding. The key risk is that any slip in operating performance could quickly erode this still-fragile cash cushion.


Competitive Edge

Competitive Edge CareCloud operates in a highly competitive healthcare IT market that includes large, well-funded rivals and many specialized niche players. Its edge appears to come from an integrated suite of products—covering electronic health records, practice management, revenue cycle, and patient engagement—that can become deeply embedded in a provider’s workflow, raising switching costs. Longstanding data assets and experience with smaller and mid-sized providers, combined with cost-efficient offshore operations, give it some cost and product differentiation. However, winning and retaining customers in this space requires constant innovation, strong service, and the ability to keep pace with regulatory and reimbursement changes, so its position is defensible but far from unassailable.


Innovation and R&D

Innovation and R&D The company is leaning heavily into AI as a core differentiator, with initiatives like cirrusAI for clinical documentation and AI-powered front-desk automation aimed at reducing administrative burden for providers. A dedicated AI Center of Excellence and a dual-shore engineering model indicate a structured, scalable approach to R&D, not just isolated experiments. Recent acquisitions in inpatient EHR and analytics extend its technology footprint from clinics into hospitals, potentially broadening the addressable market and data pool for its AI tools. The opportunity is significant if adoption is strong, but execution risk is high: integrating acquisitions, proving tangible benefits from AI, and navigating data privacy and regulatory issues will all be critical tests.


Summary

CareCloud looks like a small, operationally cash-generative healthcare IT player that is still working through a transition from uneven profitability toward a more stable, efficient model. Its financials show modest but real strengths—positive operating cash flow, moderate leverage, and a return to operating profit—offset by flat revenue, thin margins, and a reduced but still positive equity base. Strategically, the company is betting on AI-enabled automation and an integrated platform, reinforced by targeted acquisitions, to carve out a defensible niche in a crowded market. The main opportunities lie in scaling its AI solutions and cross-selling a broader product suite, while the main risks center on execution, integration, competitive pressure, and the limited financial cushion that comes with its current size and profitability profile.